Quadramet (samarium-153 lexidronam pentasodium)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Quadramet (samarium-153 lexidronam pentasodium), covering 2011-05-16 to 2011-05-16. Get the full timeline:
Most recent: Clinical Trial Update: Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant [Phase 1, Phase 2]